Bonner, N.
Bozzi, S.
Morgan, L.
Mason, B.
Peterschmitt, M. J.
Fischer, T. Z.
Arbuckle, R.
Reaney, M.
Funding for this research was provided by:
Sanofi
Article History
Received: 30 March 2020
Accepted: 12 July 2020
First Online: 5 August 2020
Ethics approval and consent to participate
: The study was conducted in accordance with the Declaration of Helsinki and approved and overseen by Copernicus Group Independent Review Board (IRB), a centralized review board in the US (reference: ADE1–17-542). Patients and clinicians provided written informed consent prior to any study activities including the collection of any of their data.
: Not applicable.
: The study was funded by Sanofi, who commissioned Adelphi Values, a health outcomes agency by whom N Bonner, L Morgan, B Mason and R Arbuckle are employed to conduct this research. S Bozzi, J Peterschmitt are employed by Sanofi. M Reaney and TZ Fischer were employed by Sanofi at the time this research was conducted. No other conflicts are reported.The authors declare that they have other no competing interests in this manuscript.